These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 36342715)

  • 1. Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.
    Lai SM; Keighley J; Garimella S; Enko M; Parker WP
    JAMA Netw Open; 2022 Nov; 5(11):e2240657. PubMed ID: 36342715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.
    Cao Y; Zhang W; Li Y; Fu J; Li H; Li X; Gao X; Zhang K; Liu S
    Prostate; 2021 Oct; 81(14):1071-1077. PubMed ID: 34320230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.
    Burgess L; Aldrighetti CM; Ghosh A; Niemierko A; Chino F; Huynh MJ; Efstathiou JA; Kamran SC
    JAMA Netw Open; 2022 May; 5(5):e2211869. PubMed ID: 35576008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
    Dall'Era MA; deVere-White R; Rodriguez D; Cress R
    Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.
    Alba C; Zheng Z; Wadhera RK
    JAMA Health Forum; 2024 Feb; 5(2):e235058. PubMed ID: 38306093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.
    Kensler KH; Pernar CH; Mahal BA; Nguyen PL; Trinh QD; Kibel AS; Rebbeck TR
    J Natl Cancer Inst; 2021 Jun; 113(6):719-726. PubMed ID: 33146392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
    JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening.
    Chen T; Kharazmi E; Fallah M
    JAMA Netw Open; 2023 Apr; 6(4):e238893. PubMed ID: 37074714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.
    O'Halloran AC; Holstein R; Cummings C; Daily Kirley P; Alden NB; Yousey-Hindes K; Anderson EJ; Ryan P; Kim S; Lynfield R; McMullen C; Bennett NM; Spina N; Billing LM; Sutton M; Schaffner W; Talbot HK; Price A; Fry AM; Reed C; Garg S
    JAMA Netw Open; 2021 Aug; 4(8):e2121880. PubMed ID: 34427679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.
    Jemal A; Culp MB; Ma J; Islami F; Fedewa SA
    J Natl Cancer Inst; 2021 Jan; 113(1):64-71. PubMed ID: 32432713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
    Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
    JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013.
    Houston KA; King J; Li J; Jemal A
    J Urol; 2018 Mar; 199(3):676-682. PubMed ID: 28965781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer.
    Rasmussen KM; Patil V; Li C; Yong C; Appukkuttan S; Grossman JP; Jhaveri J; Halwani AS
    JAMA Netw Open; 2023 Oct; 6(10):e2337272. PubMed ID: 37819658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening.
    Leapman MS; Wang R; Park H; Yu JB; Sprenkle PC; Cooperberg MR; Gross CP; Ma X
    JAMA Oncol; 2022 Jan; 8(1):41-47. PubMed ID: 34762100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer.
    Suarez-Almazor ME; Pundole X; Cabanillas G; Lei X; Zhao H; Elting LS; Lopez-Olivo MA; Giordano SH
    JAMA Netw Open; 2022 Apr; 5(4):e225432. PubMed ID: 35363269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020.
    Pompa IR; Ghosh A; Bhat S; Ragala S; Nwiloh A; Rasheed N; Chino F; Willers H; Goldberg S; Kamran SC
    JAMA Oncol; 2023 Aug; 9(8):1090-1098. PubMed ID: 37382965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans.
    Sherer MV; Qiao EM; Kotha NV; Qian AS; Rose BS
    JAMA Oncol; 2022 Oct; 8(10):1471-1476. PubMed ID: 35925581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Incidence of Metastatic Prostate Cancer in the US.
    Desai MM; Cacciamani GE; Gill K; Zhang J; Liu L; Abreu A; Gill IS
    JAMA Netw Open; 2022 Mar; 5(3):e222246. PubMed ID: 35285916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.